Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of Peptic Ulcer Bleed study.
Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model.
Routine assessment of patient-reported outcomes in behavioral health: room for improvement.
STAT3 regulation by S-nitrosylation: implication for inflammatory disease.
Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.
Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2009 Apr 07; 150(7):455-64.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Combined Modality Therapy
Esomeprazole
Female
Follow-Up Studies
Hemostasis, Endoscopic
Humans
Infusions, Intravenous
Injections, Intravenous
Male
Middle Aged
Peptic Ulcer Hemorrhage
Proton Pump Inhibitors
Retreatment
Secondary Prevention
authors with profiles
Robert K. Stuart